We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Redesigned MabThera for Treatment of ALS

News   May 26, 2017 | Original Story from Ben-Gurion University of the Negev

 
Academic Redesigns FDA-Approved MabThera to Treat ALS

Dr. Rachel Lichtenstein, Ben-Gurion University of the Negev

 
 
 

RELATED ARTICLES

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

How Anti-psychotic Medications Drive Weight Gain

News

About three million Americans take antipsychotic medications for conditions such as bipolar disorder, PTSD and schizophrenia. These medications are vital for mental health, yet many people stop taking them because of the side effects of weight gain and associated metabolic diseases.

READ MORE

CRISPR-edited Stem Cells Reveal New Contributors to Diabetes Development

News

Chronic cellular stress mechanisms have been linked to the poor development of insulin-producing cells, in a study using gene-edited stem cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE